Clinical trial registry record

A Study of Disease Progression in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

A registered study indexed because it matched monitored longevity research terms. Registry status: Terminated. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Terminated.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated August 26, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT02479386
Last registry update
August 26, 2026
Status
Terminated
Phase
Phase not reported
Sponsor
Hoffmann-La Roche
Enrollment
296
Countries
United States, Argentina, Australia, Austria, Brazil, Canada, France, Germany, Greece, Hungary, Israel, Italy, Poland, Spain, United Kingdom
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Terminated. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
OBSERVATIONAL
Evidence population
Human clinical study registration
Participants
296
Population
ALL · 50 Years
Duration
2015-06-24 to 2018-01-31
Intervention
No intervention
Comparator
Not reported
Outcomes measured
Number of Scotomatous Points as Assessed by Mesopic Microperimetry (MP) — Baseline up to end of study (up to approximat…; Macular Sensitivity as Assessed by Mesopic MP — Baseline up to end of study (up to approximately 48 months); Best Corrected Visual Acuity (BCVA) Score as Assessed by Early Treatment Diabetic Retinopathy Study (ETDRS) Chart — Bas…; BCVA Score as Assessed by ETDRS Chart Under Low Luminance Conditions — Baseline up to end of study (up to approximately…; Monocular and Binocular Reading Speed as Assessed by the Minnesota Low-Vision Reading Test (MNRead) or by Radner Readin…; Monocular and Binocular Critical Print Size as Assessed by the MNRead or by Radner Reading Cards — Baseline up to end o…; Change from Baseline in the GA area, as Assessed by Fundus Autofluorescence (FAF) — Baseline, end of study (up to appro…; Change from Baseline in National Eye Institute Visual Functioning Questionnaire 25-item Version (NEI VFQ-25) Score — Ba…; Change from Baseline in Functional Reading Independence (FRI) Index Score — Baseline, end of study (up to approximately…; Percentage of Participants With Medical Events of Interest (MEIs) — Baseline up to end of study (up to approximately 48…
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Vision ageing · 100%Title contains controlled term: age-related macular degeneration. Abstract contains controlled term: age-related macular degeneration. Title supplies longevity context: age-related. Study type is explicitly identified as OBSERVATIONAL.

Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.

vision aging
Open primary sourceExport JSON